Skip to main content
. 2012 Oct 11;31(1):85. doi: 10.1186/1756-9966-31-85

Figure 3.

Figure 3

Kaplan-Meier analysis for the overall survival of the patients with low-grade gliomas according to the serum level of anti-SH3GL1 autoantibody. The patients with higher serum level of anti-SH3GL1 autoantibody (solid line) survived significantly longer than those with lower levels (gray line) (p = 0.0124).